title: Developments in precision medicine: Studies highlight new applications for cancer chemoprevention, treatment.
authors.forename: Carrie
authors.initials: C
authors.lastname: Printz
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D018890:Chemoprevention; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D000069347:Erlotinib Hydrochloride / Q000627:therapeutic use*; D047628:Estrogen Receptor alpha / Q000235:genetics; D005260:Female; D006801:Humans; D019656:Loss of Heterozygosity / Q000235:genetics; D009062:Mouth Neoplasms / Q000517:prevention & control*; D011230:Precancerous Conditions / Q000188:drug therapy* / Q000235:genetics; D057285:Precision Medicine / Q000639:trends*
chemical_list: D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors; C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D000069347:Erlotinib Hydrochloride